Common Drugs for Stabilization of Renal Function in the Progression of Diabetic Nephropathy and Their Relations with Hypertension Therapy

Author(s): Yuxuan Wang, Chengcheng Wang, Xiuli Zhang, Harvest F. Gu*, Liang Wu*

Journal Name: Current Diabetes Reviews

Volume 14 , Issue 2 , 2018

Become EABM
Become Reviewer
Call for Editor


Introduction: Diabetic nephropathy is characterized by hypertension, progressive albuminuria, glomerulosclerosis and declines in glomerular filtration rate leading to end stage renal disease. Although the pathogenesis of diabetic nephropathy is not fully understood, current treatment of the patients with diabetic nephropathy is mainly based upon the control of hyperglycaemia and management of blood pressures.

Background: Several drugs, which are originally developed for hypertension therapy, have been adopted for stabilization of renal function in diabetic nephropathy. In this review, we first discussed the relationships between diabetic nephropathy and hypertension particularly in the renin-angiotensinaldosterone system. We then summarized chemical structures, pharmacological characteristics and clinical studies of the common drugs used for treatment of diabetic nephropathy, while these drugs have effects against hypertension.

Conclusion: This review may provide the constructive information for further drug development in diabetic nephropathy.

Keywords: Diabetic nephropathy, hypertension, renin-angiotensin-aldosterone system, renal function, angiotensin, ACE inhibitor.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 15 March, 2018
Page: [149 - 161]
Pages: 13
DOI: 10.2174/1573399813666170214112115
Price: $65

Article Metrics

PDF: 34